Despite some similarities, the lung composition of microbes and their antimicrobial resistance profiles differed between people with bronchiectasis and…
Articles by Steve Bryson, PhD
Scientists at the Broad Institute of MIT and Harvard have created a gene editing technology that may be able to…
CF AMR Syndicate, a U.K. research support group, has awarded BioVersys up to £500,000 ($636,000) to develop small…
A single dose of 4D Molecular Therapeutics’ inhaled gene therapy candidate 4D-710 improved or stabilized lung function in adults…
A miniaturized wearable device is able to measure chloride levels in sweat, the gold standard tool for diagnosing cystic…
Newborn screening (NBS) in Switzerland correctly identified 96% of cystic fibrosis (CF) cases over an 11-year period, a study…
After starting Trikafta, people with cystic fibrosis (CF) significantly reduced their use of other CF-related medications, suggesting that many…
Pulmonary ionocytes, a rare airway cell type that produces high levels of CFTR — the protein that’s defective in…
The European Commission (EC) has expanded the approval of Kalydeco (ivacaftor) for the treatment of infants with cystic…
A grant of $500,000 in Australian dollars (around $326,000) will support researchers there in the development of antibiotics formulated with…